A new nasal spray vaccine formula developed at Stanford has shown promise in protecting mice against a wide range of diseases. The formula may potentially offer broad protection against various respiratory infections and allergens, including the common cold, flu, and covid. However, it is unclear if the vaccine has been tested in humans, as some reports mention a vaccine designed by ai being used in human subjects, while others appear unrelated to the vaccine story.